finchannel.comOCT 72 min read$MCK

McKesson Plans $1.4 Billion Stake in $5.8 Billion Option Care Buyout

McKesson plans a $1.4B investment for a 49% stake in Option Care Health, part of a $5.8B buyout by Clayton, Dubilier & Rice. Shareholders will receive $32.05 per share. The deal, pending approvals, is expected to close in early 2027. Option Care shares rose 32.7% on the news. McKesson's Q1 revenue grew 8% to $105.4B, with net income down 22% to $614M.

Original reporting

finchannel.com

Published Oct 7, 2026, 10:56 AM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 7, 2026, 12:06 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

McKesson Plans $1.4 Billion Stake in $5.8 Billion Option Care Buyout — source image — Source · finchannel.com

Decision brief

The 30-second read

$MCKBullishHigh

Why it matters

The transaction creates a sizable platform in infusion services, likely improving McKesson's margin profile while offering Option Care shareholders a substantial premium.

Market read

A major M&A deal in the healthcare sector with immediate price moves for both parties.

What to watch

Regulatory approval risk and potential financing constraints for McKesson could delay closing.

Relevance 9/10Novelty 9/10Timing: today

Background

McKesson, a leading pharmaceutical distributor, is expanding its specialty‑care footprint through a near‑$6 B acquisition of Option Care Health.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$MCKBullishHigh confidence

Context

McKesson announced a $1.4 B investment for a 49% stake in Option Care Health, a $5.8 B M&A transaction.

Expected impact

modest upside as investors price in the strategic acquisition

Evidence & confidence

McKesson shares already rose 0.7% on the news; the size and strategic fit suggest further buying pressure.

$OPCHNeutralMedium confidence

Context

Option Care Health shares jumped 32.7% after the acquisition offer, and the company will become privately held.

Expected impact

potential short‑term pressure as the stock is delisted after the premium is realized

Evidence & confidence

The premium has already been priced in; post‑close trading will likely see limited upside.

Market effects

Sector

Strengthens the specialty‑care and infusion‑services segment, potentially boosting related suppliers.

Regional

U.S. healthcare M&A activity may see heightened interest.

Global

Large deal size underscores continued consolidation in global health services.

Counterpoint

What could challenge this read

The premium may be excessive if integration costs rise, suggesting caution.

Key entities

company
McKesson
U.S. pharmaceutical distributor and acquirer.
company
Option Care Health
Infusion‑services provider being acquired.
private equity
Clayton, Dubilier & Rice
Current majority owner of Option Care Health.

Read at source ← All news

OCT 27

$CAHMed

Cardinal Health, McKesson awarded $2.7B and $741.5M DLA contracts respectively

Cardinal Health (CAH) and McKesson (MCK) won DLA contracts worth $2.7B and $741.5M respectively for medical surgical supplies. The contracts last until 2029 with option periods. Customers include military branches and health agencies. Defense working capital funds from 2027-2030 will finance the contracts.

tipranks.com2 min

OCT 27

$MCKLow

Built and Bred

McKesson (MCK) will invest $179M in a 330,000 sq. ft. regional distribution center in Moore, Oklahoma, creating 200+ jobs. The site's location, readiness, and regional coordination influenced the decision, according to the company.

citylifestyle.com2 min

OCT 10

$OPCHMed

Key deals this week: Option Care Health, PTC, Energy Transfer and more

Service Properties Trust (SSVC) received a $2.0B acquisition offer from TKO LLC. Viatris (VTRS) agreed to buy Pacira BioSciences (PCRX) for $1.65B. Option Care Health (OPCH) surged 34% after a $5.8B acquisition deal with CD&R and McKesson (MCK). Energy Transfer (ET) will acquire Vaquero Midstream for $2.625B. Emera (EMA) and Canadian Utilities (CDUAF) agreed to a $10B merger. Cenovus Energy (CVE) will acquire Athabasca Oil (ATHOF) for ~$5.7B.

tradingview.com1 min

OCT 10

$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min

OCT 9

$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min